Institutional investors purchased a net $270.3 thousand shares of OHRP during the quarter ended December 2017, and now own 14.34% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
THE VANGUARD GROUP, INC. Bought 296.9 Thousand shares of OHR Pharmaceutical Inc
GEODE CAPITAL MANAGEMENT LLC Bought 129.7 Thousand shares of OHR Pharmaceutical Inc